Sanofi Logo

Sanofi

SAN | PA

Overview

Corporate Details

ISIN(s):
FR0000120578 (+39 more)
LEI:
549300E9PC51EN656011
Country:
France
Address:
46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sanofi is a global biopharmaceutical company dedicated to the research, development, manufacturing, and marketing of a wide range of healthcare solutions. The company's core activities focus on discovering and delivering innovative medicines and vaccines to improve the lives of people worldwide. Its portfolio encompasses prescription pharmaceuticals, over-the-counter medications, and a significant vaccine division, making it one of the world's largest vaccine producers. Sanofi is an R&D-driven organization that integrates AI and digital technologies to advance its therapeutic pipeline. The company operates globally, with specialized subsidiaries such as Ablynx, Kymab, and Synthorx contributing to its research efforts in various medical fields.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Sanofi. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-02 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
French 2.9 MB
2025-09-02 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.9 MB
2025-08-25 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.4 MB
2025-08-18 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 2.7 MB
2025-08-18 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juill…
French 121.9 KB
2025-08-18 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 2.7 MB
2025-08-18 18:30
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares - J…
English 144.2 KB
2025-08-11 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 3.0 MB
2025-08-04 18:30
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
English 3.1 MB
2025-08-04 18:30
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
English 3.1 MB
2025-07-31 18:20
Report Publication Announcement
Press release: Online availability of Sanofi’s half-year financial report for 2…
English 115.2 KB
2025-07-31 18:20
Report Publication Announcement
Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sa…
French 115.0 KB
2025-07-31 00:00
Interim Report
Sanofi - Rapport semestriel 2025
French 1.6 MB
2025-07-22 07:30
M&A Activity
Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de v…
French 193.0 KB
2025-07-22 07:30
M&A Activity
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeli…
English 193.8 KB

Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sanofi via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-02 N/A Other Buy 71,423 N/A
2024-04-26 N/A Other Buy 1,000 91,380.00 EUR
2023-06-09 N/A Other Buy 9 856.04 EUR
2023-05-02 N/A Other Buy 65,205 6,364,008.00 EUR
2023-05-02 N/A Other Buy 500 48,835.00 EUR

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK